Halozyme Therapeutics shares owned by Oppenheimer Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Oppenheimer Asset Management
from 13F filings
Historical chart of Oppenheimer Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Oppenheimer Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $2.0M | 42k | 47.81 |
| 2024-09-30 | $2.9M | 50k | 57.24 |
| 2024-06-30 | $1.4M | 26k | 52.36 |
| 2024-03-31 | $919k | 23k | 40.68 |
| 2023-09-30 | $1.1M | 28k | 38.20 |
| 2023-06-30 | $1.0M | 28k | 36.07 |
| 2023-03-31 | $1.1M | 28k | 38.19 |
| 2022-12-31 | $2.6M | 46k | 56.90 |
| 2022-09-30 | $1.7M | 43k | 39.51 |
| 2022-06-30 | $1.7M | 39k | 43.93 |
| 2022-03-31 | $1.5M | 39k | 39.75 |
| 2021-12-31 | $1.5M | 38k | 40.18 |
| 2021-09-30 | $1.7M | 43k | 40.64 |
| 2021-06-30 | $1.5M | 33k | 45.41 |
| 2021-03-31 | $1.4M | 33k | 41.70 |
| 2020-12-31 | $977k | 23k | 42.67 |
| 2020-09-30 | $592k | 23k | 26.30 |
| 2020-06-30 | $585k | 22k | 26.74 |
| 2020-03-31 | $61k | 3.4k | 17.89 |
More positions owned by Oppenheimer Asset Management
View all positions for Oppenheimer Asset Management